new self tirzepatide (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects F.D.A. Approves New Obesity Drug

Nausea with popcorn is uncommon but can occur if eaten too quickly or in large volume, since the medication slows stomach emptying

10.1083/jcb.58.2.390 10

Because this drug has received approval for an accepted medical indication, Part D plan sponsors can add it to their formularies now and cover the medication

Short follow-up

In the REDEFINE 1 phase 3 trial (NCT05567796), which enrolled adults with overweight or obesity (BMI 27 kg/m) and at least 1 weight-related comorbidity but without type 2 diabetes, participants receiving CagriSema (cagrilintide 2.4 mg + semaglutide 2.4 mg) achieved a mean body weight reduction of 22.7% from baseline after 68 weeks among adherent participants, compared with approximately 3% in the placebo group.5 These results establish CagriSema as one of the most potent antiobesity therapies investigated to date

You can inject tirzepatide into the abdomen, thigh, or upper arm